Resilient Healthcare Corp
NRPR
Other OTC0.02
USD
- -
- -
ISIN
US76090K1060
Return %
Stock
S&P500
1Y
-4.76
18.02
3Y
-12.66
64.11
5Y
-33.55
72.15
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Godfrey Yew
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 6780 Caballo Street Las Vegas NV United States of America 89119
- IPO Date
- Nov 6, 2002
- Website
- o2pus.com
- Similar Companies
- Business
- Nutri Pharmaceuticals Research, Inc. (NRPR) manufactures and sells health, beauty, and food ingredients, vitamins, and supplements worldwide through its proprietary O2P oil-to-powder conversion process that transforms edible oils into free-flowing powders while preserving enzymes and active ingredients; the company offers over 50 standard powders in Nutri Grade, Food Grade, Cosmetic Grade, Pet Food, and Animal Feed Grades, including custom tolling services for proprietary oils used in finished goods such as food, pet food, nutraceuticals, vitamin supplements, cosmetics, and organic household products. Founded in 1994 and headquartered in Las Vegas, Nevada, Nutri Pharmaceuticals Research operates all activities through its subsidiary Natuurs, LLC, targeting nutraceutical, food and beverage, sports nutrition, personal care, cosmeceutical, and pet industries with more than 25 million pounds of powder sold to over 200 business customers. In June 2021, the company acquired Natuurs, LLC, shifting focus to Amazon.com marketing and distribution alongside CBD product development following the divestment of prior O2P assets; in November 2025, it changed its name to Resilient Healthcare Corp.